240 related articles for article (PubMed ID: 10762021)
1. COX-2 and colon cancer: potential targets for chemoprevention.
Fournier DB; Gordon GB
J Cell Biochem Suppl; 2000; 34():97-102. PubMed ID: 10762021
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenases and colon cancer.
Kawai N; Tsujii M; Tsuji S
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
5. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
6. COX selectivity and animal models for colon cancer.
Oshima M; Taketo MM
Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
[TBL] [Abstract][Full Text] [Related]
7. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in inducible cyclooxygenase (COX-2) inhibition.
de Leval X; Delarge J; Somers F; de Tullio P; Henrotin Y; Pirotte B; Dogné JM
Curr Med Chem; 2000 Oct; 7(10):1041-62. PubMed ID: 10911017
[TBL] [Abstract][Full Text] [Related]
10. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
Reddy BS; Rao CV
J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
[TBL] [Abstract][Full Text] [Related]
13. Screening for colon cancer and evaluation of chemoprevention with coxibs.
Rex DK
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S41-50. PubMed ID: 11992750
[TBL] [Abstract][Full Text] [Related]
14. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
[TBL] [Abstract][Full Text] [Related]
16. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut.
Grover JK; Yadav S; Vats V; Joshi YK
Int J Colorectal Dis; 2003 Jul; 18(4):279-91. PubMed ID: 12774242
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs and chemoprevention.
Rao CV; Reddy BS
Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
[TBL] [Abstract][Full Text] [Related]
18. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT
Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083
[TBL] [Abstract][Full Text] [Related]
20. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
